Serologic Screening before Endoscopy: The Value of Helicobacter pylori Serology, Serum Recognition of the CagA and VacA Proteins, and Serum Pepsinogen I

References

• Working Party of the Clinical Services Committee of the British Society of Gastroenterology. Provision of gastrointestinal endoscopy and related services for a district general hospital. Gut 1991;32:95–105.
   PubMedGoogle Scholar
• Gear MWL, Wilkinson SP. Open access upper alimentary endoscopy. Br J Hosp Med 1989;41:438–44.
   PubMed Web of Science ®Google Scholar
• Williams B, Luckas M, Ellingham JHM, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet 1988;2:1349–51.
   Google Scholar
• Bodger K, Daly MJ, Heatley RV. Clinical economics review: Helicobacter pylori-associated peptic ulcer disease. Aliment Pharmacol Ther 1997;11: 273–82.
   PubMedGoogle Scholar
• Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41:513–7.
   PubMed Web of Science ®Google Scholar
• Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;338:94–6.
   PubMed Web of Science ®Google Scholar
• Mendall MA, Goggin PM, Marrero JM. Role of Helicobacterpylori serology in screening prior to endoscopy. Eur J Gastroenterol Hepatol 1992;4:713–7.
   Google Scholar
• Patel P, Mendall MA, Khulusi S, Molineux N, Levy J, Maxwell JD, et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 1994;344:511–2.
   PubMed Web of Science ®Google Scholar
• Vyas SK, Sharpstone D, Treasure J, Fine D, Hawtin PR. Preendoscopy screening using serodiagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994;6:783–5.
   Google Scholar
• Patel P, Khulusi S, Mendall MA, Lloyd R, Jazrawi R, Maxwell JD, et al. Prospective screening of dyspeptic patients by H. pylori serology. Lancet 1995;346:1315–8.
   PubMed Web of Science ®Google Scholar
• Mendall MA, Jazrawi RP, Marrero JM, Molineux N, Levy J, Maxwell JD, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995;36:330–3.
   PubMed Web of Science ®Google Scholar
• British Society of Gastroenterology. Dyspepsia management guidelines. In: BSG guidelines in gastroenterology. London: BSG; 1996.
   Google Scholar
• Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997;40:701–3.
   PubMed Web of Science ®Google Scholar
• Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33: 1496–500.
   Google Scholar
• Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Thompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332–5.
   PubMed Web of Science ®Google Scholar
• Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JG, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;73:760–70.
   Google Scholar
• Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996;91:949–53.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777–80.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111–5.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative H. pylori infection. Gut 1997;40:297–301.
   PubMed Web of Science ®Google Scholar
• Atherton JC. H. pylori virulence factors. Br Med Bull 1998;54: 105–20.
   PubMed Web of Science ®Google Scholar
• Rautelin H, Blomberg B, Jarnerot G, Danielson D. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol 1994;29:128–32.
   PubMed Web of Science ®Google Scholar
• Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33:1203–5.
   Google Scholar
• Fox JG, Correa P, Taylor NS, Thompson N, Fontham F, Janney F, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with a high prevalence of atrophic gastritis. Am J Gastroenterol 1992;87: 1554–60.
   PubMedGoogle Scholar
• Trier JS. Morphology of the gastric mucosa in patients with ulcer diseases. Am J Dig Dis 1979;21:138–40.
   Google Scholar
• Correa P. Chronic gastritis: a clinico-pathologic classification. Am J Gastroenterol 1988;83:504–9.
   PubMed Web of Science ®Google Scholar
• Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982;83: 204–9.
   Google Scholar
• Kreuning J, Lindeman J, Biedmond I, Lamers CBHW. Serological parameters in assessment of degree of gastritis in healthy volunteers. Dig Dis Sci 1995;609–14.
   PubMedGoogle Scholar
• Samloff IM, Liebman WM, Panitch NM. Serum group I pepsinogens by radioimmunassay in control subjects and patients with peptic ulcer. Gastroenterology 1975;69:83–90.
   Google Scholar
• Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;26 Suppl 186:109–16.
   Google Scholar
• Webb PM, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, et al. The epidemiology of low serum pepsinogen I levels and an international association with gastric cancer rates. Gastroenterology 1994;107:1335–43.
   PubMed Web of Science ®Google Scholar
• Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785–8.
   PubMed Web of Science ®Google Scholar
• Feldman RA, Deeks JJ, Evans SJW. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995;14:428–33.
   Google Scholar
• Wilcox WH, Dent TH, Hunter JO, Gray JJ, Brown DF, Wight DG, et al. Accuracy of serology for the diagnosis of Helicobacter pylori infection—a comparison of eight kits. J Clin Pathol 1996;49:373–6.
   PubMedGoogle Scholar
• Figura N, Oderda G, Verdani S. Evaluation of a commercial ELISA kit for the serological diagnosis of Helicobacter pylori infection. New Microbiol 1994;17:319–25.
   Google Scholar
• Maconi G, Vago L, Galletta G, Imbesi V, Sangaletti O, Parente F, et al. Is routine histological evaluation an accurate test for Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13: 327–31.
   PubMedGoogle Scholar
• McColl KEL, El-Nujumi A, Murray L, El-Omar E, Gillen D, Dickson A, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302–6.
   PubMed Web of Science ®Google Scholar
• Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993;61: 5008–12.
   Google Scholar
• Perez-Perez GI, Tham KT, Peek RM, Atherton JC, Blaser MJ, Cover JL. Serologic responses to type m1 and m2 H. pylori VacA antigens. Gut 1997;41:A110.
   Google Scholar
• Chang FY, Cheng JT, Lee FY, Wang TF, Lai KH, Lee SD, et al. Serum pepsinogen I levels in patients with non-ulcer dyspepsia. J Gastroenterol Hepatol 1990;5:271–6.
   PubMed Web of Science ®Google Scholar
• Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Corbett M, et al. H. pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73: 819–24.
   Google Scholar
• Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prevent 1993;2:461–6.
   PubMedGoogle Scholar
• Goodbourn C, Teare EL, Saverymuttu S, Khin C. Pre-endoscopy screening for Helicobacter [letter]. Lancet 1996;347:699–700.
   PubMedGoogle Scholar
• Bodger K, Daly MJ, Heatley RV. Dyspepsia workload in primary care. Gut 1996;39 Suppl 1:A1.
   Google Scholar
• Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811–6.
   Google Scholar
• Hungin APS, Thomas PR, Bramble MG, Corbett WA, Idle N, Contractor BR, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract 1994;44:519–21.
   PubMed Web of Science ®Google Scholar